Chloroethylnorapomorphine
From Self-sufficiency
Revision as of 20:21, 14 July 2010 by Citation bot 1 (Talk) (Citations: [Pu173] added: last2, first2. You can use this bot yourself! Report bugs here.)
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (February 2009) |
| Chloroethylnorapomorphine | |
|---|---|
| File:Chloroethylnorapomorphine.png | |
| 6-(2-Chloro-ethyl)-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol | |
| Other names (-)-N-(2-Chloroethyl)-norapomorphine | |
| style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
| CAS number | 75946-94-0 |
| PubChem | 156376 |
| SMILES | Script error: No such module "collapsible list". |
| style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
| Molecular formula | C18H18ClNO2 |
| Molar mass | 315.79 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
Chloroethylnorapomorphine is a chemical once thought to be an irreversible dopamine D2 receptor antagonist;[1][2] however, it was later proved to be reversible.[3]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ Cohen SA, Neumeyer JL. Aporphines. 50. Kinetics of solvolysis of N-(2-chloroethyl)norapomorphine, an irreversible dopamine receptor antagonist. Journal of Medicinal Chemistry. 1983 Oct;26(10):1348-53. PMID 6620296
- ↑ Guan JH, Neumeyer JL, Filer CN, Ahern DG, Lilly L, Watanabe M, Grigoriadis D, Seeman P. Aporphines. 58. N-(2-chloroethyl) [8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application. Journal of Medicinal Chemistry. 1984 Jun;27(6):806-10. PMID 6737423
- ↑ Lehmann, J; Langer, SZ (1982). "Dopamine autoreceptors differ pharmacologically from postsynaptic dopamine receptors: Effects of (−)-N-(2-chloroethyl)-norapomorphine". European Journal of Pharmacology. 77 (1): 85. doi:10.1016/0014-2999(82)90542-8. PMID 7060630.
